Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types

Siân Jones1, Meng Li, D Williams Parsons

  • 1Ludwig Center for Cancer Genetics and Therapeutics and Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA.

Human Mutation
|October 20, 2011
PubMed

Insights

Mutations in the ARID1A gene, a chromatin remodeling gene, are common in ovarian clear cell carcinomas. This study found ARID1A mutations in 6% of various cancers, particularly gastrointestinal tumors, suggesting its role in diverse neoplasm development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the ARID1A gene are frequently observed in ovarian clear cell carcinomas (OCCCs).
  • ARID1A plays a crucial role in chromatin remodeling, influencing gene expression and cellular processes.
  • Understanding the broader mutational landscape of ARID1A is essential for comprehending its role in tumorigenesis.

Purpose of the Study:

  • To investigate the prevalence and spectrum of ARID1A mutations across a wide range of human malignant neoplasms.
  • To identify specific tumor types where ARID1A alterations are common.
  • To explore potential correlations between ARID1A mutations and clinicopathological features like microsatellite instability (MSI).

Main Methods:

  • Genomic DNA analysis of 759 malignant neoplasms from various origins (pancreas, breast, colon, stomach, lung, prostate, brain, blood).
  • Sequencing and mutation analysis to detect truncating and nontruncating somatic mutations in the ARID1A gene.
  • Assessment of microsatellite instability (MSI) status in tumors harboring ARID1A mutations.

Main Results:

  • ARID1A mutations were identified in 6% of the evaluated neoplasms, with an additional 0.4% showing nontruncating somatic mutations.
  • Colorectal (10%) and gastric (10%) neoplasms showed the highest frequency of ARID1A mutations.
  • Over half of mutated colorectal and gastric cancers exhibited microsatellite instability (MSI), often linked to frameshift mutations at mononucleotide repeats.

Conclusions:

  • ARID1A inactivation, leading to aberrant chromatin remodeling, is implicated in the development of a diverse array of cancers beyond OCCCs.
  • The high prevalence in gastrointestinal cancers, especially those with MSI, highlights a specific pathway of ARID1A-driven tumorigenesis.
  • These findings underscore the importance of ARID1A as a potential therapeutic target across multiple cancer types.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...